SEC Filings TLDR

On August 5, 2025, Douglas N. Benham, a director of American Homes 4 Rent (AMH), filed a Form 4 with the SEC detailing transactions in the company's Class A Common Shares. Benham acquired 10,000 shares at a price of $15.26 per share, increasing his total holdings to 32,227 shares. Additionally, Benham holds 6,991 share...

John Holmes III, Chairman, President & CEO of AAR CORP, sold 10,000 shares of common stock on August 7, 2025, at a weighted average price of $71.6994. The shares were sold in multiple transactions ranging from $71.6000 to $72.2500. Following this transaction, Holmes owns 298,603 shares of AAR CORP. The sale was reporte...

On August 6, 2025, American International Group, Inc. (AIG) sold 30 million shares of Corebridge Financial, Inc. (CRBG) common stock at a price of $33.65 per share. This transaction reduced AIG's ownership in Corebridge Financial to 83,896,013 shares. AIG is a ten percent owner of Corebridge Financial. The filing, subm...

Nicholas J. Donoghoe, EVP and Chief Business/Strategy Officer of AbbVie Inc., sold shares of the company's common stock on August 5, 2025. The first transaction involved the sale of 3,234.17 shares at a weighted average price of $198.27 per share. The second transaction involved the sale of 10,061 shares at a weighted ...

On August 5, 2025, Sir Jonathon Band, a director of Carnival PLC, sold 12,500 Trust Shares representing a beneficial interest in the Carnival PLC special voting share. The transaction was priced at $29.753 per share, resulting in a total sale value of approximately $371,912.50. Following this transaction, Sir Jonathon ...

The SEC filing details transactions involving Capital One Financial Corp (COF) common stock by an insider, Michael Zamsky, who serves as the Chief Credit & Financial Risk Officer. On May 18, 2025, Zamsky acquired 10 shares of COF common stock as part of the company's acquisition of Discover Financial Services. This tra...

On August 6, 2025, Sundar Pichai, the Chief Executive Officer and Director of Alphabet Inc., reported multiple transactions involving the sale of Class C Capital Stock. These transactions were executed under a Rule 10b5-1 Trading Plan adopted on December 2, 2024. The sales included 7,986 shares at a weighted average pr...

John Kent Walker, President of Global Affairs and Chief Legal Officer at Alphabet Inc., reported several transactions involving Class C Google Stock Units (GSUs) and Class C Capital Stock. The transactions were executed under a Rule 10b5-1 Trading Plan adopted by The Arete Trust on May 29, 2024. On August 4, 2025, Walk...

Guy Archibald Innes, a director of VolitionRx Ltd, reported changes in his ownership of the company's common stock. The filing details transactions and holdings as of August 5, 2025. Innes directly acquired 78,125 shares at $0.64 per share, increasing his direct ownership to 966,814 shares. Additionally, he holds share...

Cameron John Reynolds, President and CEO of VolitionRx Ltd, reported changes in his ownership of the company's common stock. On August 5, 2025, Reynolds acquired 78,125 shares at a price of $0.64 per share in a registered direct offering. Following this transaction, Reynolds directly owns 2,609,847 shares. Additionally...

On August 4, 2025, Randall Moreadith, the Chief Scientific Officer of Serina Therapeutics, Inc., filed a Form 4 with the SEC detailing transactions involving the company's common stock and stock options. Moreadith acquired 5,500 shares of common stock at a price of $0.06 per share and subsequently sold the same number ...

On July 29, 2025, Bradley C. Lalonde, a director of Northann Corp., acquired 104,598 shares of common stock under the company's 2023 Equity Incentive Plan as compensation. This transaction increased Lalonde's total holdings to 197,247 shares. The shares were acquired at a price of $0 per share, indicating they were lik...

On July 29, 2025, Umesh Patel, a director of Northann Corp. (NCL), acquired 87,146 shares of common stock as compensation under the company's 2023 Equity Incentive Plan. This transaction increased Patel's total holdings to 133,774 shares. The shares were granted at no cost, and the transaction was reported in a Form 4 ...

Transcontinental Realty Investors, Inc. has reported the purchase of shares of Income Opportunity Realty Investors, Inc. (IOR) in two separate transactions. On July 8, 2025, the company purchased 61 shares at $17.9 per share, increasing its total holdings to 3,435,470 shares. On July 29, 2025, an additional 44 shares w...

On July 29, 2025, Susan H. Murphy, a director of ACME UNITED CORP, disposed of 120 shares of the company's common stock at a price of $42.61 per share. Following this transaction, Murphy's total ownership in the company stands at 7,167 shares. The transaction was reported under Form 4, indicating a change in ownership....

On August 5, 2025, Harris H Simmons, the Chairman & CEO of ZIONS BANCORPORATION, NATIONAL ASSOCIATION, executed a transaction involving the purchase of 4,500 shares of the company's common stock. The transaction was executed at a weighted average price of $52.3457 per share, with the actual prices ranging from $52.32 t...

On August 5, 2025, Bradley L. Soultz, the CEO of WillScot Holdings Corp, engaged in several stock transactions. He transferred 5,000 shares of common stock to the Ellen M. Soultz Irrevocable Trust, which did not change his pecuniary interest in the shares. Additionally, his spouse gifted 10,000 shares to the Bradley L....

On August 6, 2025, Dan Paterson, the President and CEO of Verastem, Inc., sold 1,332 shares of the company's common stock at a price of $5.81 per share. This transaction was conducted to satisfy statutory withholding requirements related to the vesting of restricted stock units. Following this sale, Paterson still owns...

On August 5, 2025, Thomas C. Indelicarto, Executive Vice President, General Counsel & Secretary of VeriSign Inc., sold 501 shares of the company's common stock at a price of $269.50 per share. Following this transaction, Indelicarto owns 37,267.8093 shares of VeriSign Inc. The sale was reported in a Form 4 filing with ...

On August 5, 2025, Kevin Charles Gallagher, a director of UMB Financial Corp (UMBF), reported a transaction involving the sale of 460 shares of common stock at a price of $110.63 per share. Following this transaction, Gallagher directly owns 12,549.668 shares. Additionally, Gallagher indirectly owns 8,040.001 shares th...

On August 6, 2025, Winter P. Clinton, a director of United Bankshares Inc. (UBSI), reported changes in his ownership of the company's securities. Clinton acquired 278 shares of phantom stock, which are payable in cash upon termination of employment, at a price of $35.7692 per share. Following this transaction, Clinton ...

Robert F. Werner, the Chief Accounting Officer of Twist Bioscience Corp, sold 186 shares of common stock on August 4, 2025, at a price of $28.364 per share. This sale was mandated by the company's equity incentive plans to cover tax withholding obligations related to the vesting of Restricted Stock Units. The transacti...

On August 4, 2025, Emily M. Leproust, CEO and Director of Twist Bioscience Corp, sold 5,585 shares of common stock at a price of $28.364 per share. This sale was mandated by the company's equity incentive plans to cover tax withholding obligations related to the vesting of Restricted Stock Units. Following this transac...

Paula Green, the Senior Vice President of Human Resources at Twist Bioscience Corp, sold 1,255 shares of common stock on August 4, 2025, at a price of $28.364 per share. The sale was mandated to cover tax withholding obligations related to the vesting of Restricted Stock Units, as per the company's equity incentive pla...

On August 4, 2025, Dennis Cho, Senior Vice President, Chief Legal Officer & Corporate Secretary of Twist Bioscience Corp (TWST), sold 785 shares of common stock at a price of $28.364 per share. This sale was mandated by the company's equity incentive plans to cover tax withholding obligations related to the vesting of ...